Here you can see and modify the cookie settings of various tools used on and related subdomains.

Save settings
Advantage Austria Show navigation

 Fighting back against allergies with high-tech diagnositics

logo © igevia GmbH

© igevia GmbH

21. November 2019

Studies have shown that some 30% of people in Europe suffer from an allergy.  Yet it is estimated that only between 5 and 10% are aware of their own allergy status and take appropriate precautions. In Austria and Germany, it currently takes around nine years for an allergy to be properly diagnosed. igevia provides reliable testing for 273 allergens.

The small blood sample required can easily be taken from your fingertip at home or at the doctor’s and you won’t need a stamp to post it to igevia’s partner laboratory. Analysis is carried out with cutting-edge technology known as ALEX - Allergy Explorer. The results are set out clearly in an individualised igevia allergen report and are used in conjunction with igevia’s symptom questionnaire as the basis for a medical consultation to determine the steps to be taken.

With igevia, co-founders Gerhard Feilmayr and Dominik Flener have both simplified local allergy testing and reduced the time to correct diagnosis for millions of allergy sufferers throughout Europe. igevia was launched on the Austrian market in April 2018 and is currently expanding into Germany, the UK and Ireland.

Rooted in Upper Austria – used around the world: 2019 saw Upper Austria’s Export Center OÖ join forces for the second time with hub,ert, the Upper Austrian non-profits network, and ADVANTAGE AUSTRIA in search of the best international start-ups. From all the applications, 15 from Upper Austria won awards in the Hottest International Start-ups category.